Back to Search Start Over

Biofilm Formation Ability of ESBL/pAmpC-Producing Escherichia coli Isolated from the Broiler Production Pyramid.

Authors :
Laconi A
Tolosi R
Apostolakos I
Piccirillo A
Source :
Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2023 Jan 11; Vol. 12 (1). Date of Electronic Publication: 2023 Jan 11.
Publication Year :
2023

Abstract

Escherichia coli able to produce extended spectrum β-lactamases (ESBLs) and plasmid-mediated AmpC β-lactamases (pAmpCs) represents a serious threat to public health, since these genes confer resistance to critically important antimicrobials (i.e., third generation cephalosporins) and can be transferred to non-resistant bacteria via plasmids. E. coli are known to be able to form a biofilm, which represents a favorable environment for the exchange of resistance determinants. Here, we assessed the ability of 102 ESBL/pAmpC-producing E. coli isolated from the broiler production pyramid to form a biofilm and to identify genetic factors involved in biofilm formation. All but one of the ESBL/pAmpC-producing E. coli were able to form a biofilm, and this represents a great concern to public health. E. coli belonging to phylogroups D, E, and F, as well as strains harboring the blaCTX-M-type gene, seem to be associated with an increased biofilm capability (p < 0.05). Furthermore, virulence genes involved in adherence and invasion (i.e., csgBAC, csgDEFG, matABCDEF, and sfaX) seem to enhance biofilm formation in E. coli. Efforts should be made to reduce the presence of ESBL/pAmpC- and biofilm-producing E. coli in the broiler production pyramid and, therefore, the risk of dissemination of resistant bacteria and genes.

Details

Language :
English
ISSN :
2079-6382
Volume :
12
Issue :
1
Database :
MEDLINE
Journal :
Antibiotics (Basel, Switzerland)
Publication Type :
Academic Journal
Accession number :
36671356
Full Text :
https://doi.org/10.3390/antibiotics12010155